Pedersen, Lene Rørholm http://orcid.org/0000-0002-0669-8855
Olsen, Rasmus Huan
Anholm, Christian
Astrup, Arne
Eugen-Olsen, Jesper
Fenger, Mogens
Simonsen, Lene
Walzem, Rosemary L.
Haugaard, Steen Bendix
Prescott, Eva
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial
https://doi.org/10.1186/s12933-019-0934-x
Funding for this research was provided by:
Sundhed og Sygdom, Det Frie Forskningsråd (10-082982/FSS)
Hjerteforeningen (10-04-R78-A278622613)
The Faculty of Health and Medical Sciences (211-0730/10-3012)
Else og Mogens Wedell Wedellsborgs Fond (1069)
Beckett-Fonden
Article History
Received: 15 June 2019
Accepted: 21 September 2019
First Online: 1 October 2019
Ethics approval and consent to participate
: The study adheres to the Helsinki declaration and was approved by the Ethics Committee of the Capital Region of Denmark (H-4-2010-146) and the Danish Dataprotection Agency. All participants gave oral informed consent and signed written informed consent.
: Not applicable.
: JEO is a founder, shareholder and board member of ViroGates A/S, Denmark, the company that produces the suPARnostic<sup>®</sup> assay. JEO and SBH are inventors on a patent on suPAR and risk. Hvidovre Hospital, University of Copenhagen, Denmark, owns the patent, which is licensed to ViroGates A/S. The remaining authors declare that they have no competing interests.